PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,046,402 | -21.2% | 5,522,401 | +0.0% | 0.05% | -20.0% |
| Q2 2023 | $72,363,542 | +17.6% | 5,519,721 | +0.3% | 0.06% | +11.1% |
| Q1 2023 | $61,520,421 | +32.6% | 5,502,721 | 0.0% | 0.05% | +28.6% |
| Q4 2022 | $46,387,938 | -48.7% | 5,502,721 | +1.3% | 0.04% | -52.3% |
| Q3 2022 | $90,510,000 | +13.9% | 5,432,751 | +0.7% | 0.09% | +23.9% |
| Q2 2022 | $79,453,000 | -41.2% | 5,397,621 | -0.9% | 0.07% | -30.4% |
| Q1 2022 | $135,115,000 | -14.8% | 5,445,991 | +10.2% | 0.10% | -7.3% |
| Q4 2021 | $158,551,000 | +48.2% | 4,943,891 | +66.3% | 0.11% | +44.7% |
| Q3 2021 | $106,993,000 | +23.8% | 2,973,691 | +51.8% | 0.08% | +31.0% |
| Q2 2021 | $86,446,000 | +58.6% | 1,959,343 | +64.4% | 0.06% | +52.6% |
| Q1 2021 | $54,522,000 | +7.8% | 1,192,000 | +62.7% | 0.04% | 0.0% |
| Q4 2020 | $50,557,000 | – | 732,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |